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Abstract of thesis 
In this research, the author employed an epigenomic method, Assay for Transposase-Accessible Chromatin with high 
throughput sequencing (ATAC-seq), to characterize the genome-wide chromatin alterations associated with osteoarthritis 
(OA). A novel protocol to generate high-quality ATAC-seq data from fresh hard tissue, human cartilage was first established 
using collagenase II to study human OA disease.  
In chapter 1, the author introduced the background of this research, including human knee OA (i.e. current statistics, risk 
factors, diagnosis and treatments), tissue features of cartilage and subchondral bone in OA and non-OA knee joint, the 
importance of epigenetics in disease and a method to study the chromatin structure (i.e. ATAC-seq). It was pointed out that 
OA is a chronic disease affecting the aging society and the limitation of epigenetically studying OA clinical samples. The 
research objectives were proposed in this chapter using an epigenetic tool to investigate the chromatin accessible regulatory 
elements to gain further insight into the pathogenesis of OA.   
In chapter 2, the author introduced how to optimize a protocol to generate high-quality epigenomic profiling data at 
chromatin level comparing with fresh (n=8) and flash frozen (n=4) human knee cartilage tissue. To investigate the variations 
of chromatin accessibility in cartilage associated with OA, the author applied previously published modeling system 
representing damaged (iMT) and intact (oLT) cartilage region in the knee. The results showed using fresh human cartilage is 
able to generate high-quality ATAC-seq data using collagenase II to study human OA disease. Quality check qPCR method 
can be used before sequencing to test the signal to the noise ratio. It can be concluded that the ATAC-seq libraries generated 
from fresh cartilage tissue had good and indistinguishable quality between iMT and oLT regions. 
In chapter 3, the author introduced NGS data processing (i.e. peak calling and quality assessment), bioinformatic 
methods for ATAC-seq data downstream analysis and integration with other publicly available data (i.e. GWAS, DNA 
methylation and RNA-seq). The author defined a set of robust accessible chromatin regions (n=109,215) from 16 libraries 
generated from the fresh (n=8) human knee cartilage tissue, of which 71.1% were annotated as enhancers and 16.9% were 
annotated as promoters according to Roadmap DHS annotation dataset. Integrating the epigenomic data of clinically relevant 
tissues with the publicly available genetic and transcriptomic data the author identified loci may contribute to OA 
pathogenesis. Most of these annotated accessible enhancers were linked to their putative target genes using public datasets. 
With the enhancer-gene map in chondrocyte, the author identified the linked genes of the previously identified OA GWAS 
(Single Nucleotide Polymorphisms) SNPs or OA differential methylated loci located lie outside of the coding regions. The 
differentially accessible promoters (7.6%) or enhancers (85.3%) relevant to OA were identified. Further analyses for 
differential accessible enhancer regions showed bone-related enhancers are more likely to be dysregulated in OA diseased 
tissue. Consistently, 371 protein-coding genes that are dysregulated both at the transcriptomic (RNA-seq) and epigenomic 
(ATAC-seq) levels in OA with the concordant direction of change. These genes are enriched for pathways regulating 
chondrogenesis, ossification, and mesenchymal stem cell differentiation. Moreover, integrating ATAC-seq data with public 
available database also allowed to identify altered cis-regulatory elements as well as transcription factors binding. Taken 
together, abnormal self-healing in OA knee cartilage was observed in this study, suggesting induced endochondral 
ossification-like cartilage-to-bone conversion is a characteristics of OA progression. 
In chapter 4, the author summarized the conclusion. This study identified altered promoters and enhancers of genes that 
might be involved in the pathogenesis of OA. The analyses suggest aberrant enhancers associated with MSC differentiation 
and chondrogenesis in OA, and the genes that involved in the endochondral ossification signals pathway should be critical for 
OA development and progression. The single-cell transcriptomics or single-cell ATAC-seq experiment were proposed as the 
future research to investigate the osteoblast-like signal or ossification signal is from a chondrocyte undergoing terminal 
differentiation, or from MSC direct differentiation. 
 
Abstract of assessment result 
This study demonstrated genome-wide investigations of accessible chromatin regions is powerful in probing changes of 
regulatory genomic elements in clinical samples relevant to a disease. The chromatin accessibility map in cartilage will be a 
resource for future GWAS and DNA methylation studies in OA and other musculoskeletal diseases. The findings are of very 
high interest to the field, as this extensive analysis on ATAC-seq datasets on clinical samples of OA patients suggests aberrant 
enhancers associated with MSC differentiation and chondrogenesis in OA and it could expound the possible pathogenesis 
mechanism, leading to the identification of potential targets of biomarkers or therapies. Understanding these molecular bases 
of OA is necessary for future therapeutic intervention. 
The final examination committee conducted a meeting as a final examination on 20th November 2018. The applicant 
provided an overview of the dissertation, addressed questions and comments raised during the Q&A session. All of the 
committee members reached a final decision that the applicant has passed the final examination. Therefore, the final 
examination committee approved that the applicant is qualified to be awarded the degree of Doctor of Philosophy in 
Biological Science. 
 
